ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer
It has been announced that the results from the final analysis of the pivotal Phase…
Browsing: nmCRPC
It has been announced that the results from the final analysis of the pivotal Phase…